United

Equity

Shield

Patientory

Partner

Atlanta, Georgia, February 7th, 2024, Chainwire
 
Patientory Wallet Launches Telehealth Service for GLP-1 in Bid to Boost Population Health, Raises Additional Funding
February 7, 2024, Atlanta. –– Health care data startup Patientory is proud to announce the launch of its new telehealth service for weight-loss offering GLP-1 prescriptions such as Semaglutide. With the launch, Patientory aims to elevate health data democratization as it continues building the future of healthcare in Web3.&nbsp;
Patientory, whose decentralized applications include the consumer Digital Health Data Wallet, is renowned for providing clinical trial recruitment based on an individual’s data, incentivizing individuals to adapt healthy habits and contribute health data to clinical research in return for reward-based payments.
With the United States facing a critical challenge due to surging adult obesity rates, Patientory’s new service provides accessible and personalized weight loss solutions to millions. Interested consumers can use the Patientory Health Data Wallet to verify their Body Mass Index (BMI) and determine if they are eligible for a semaglutide GLP-1 prescription.&nbsp;
Provided the eligibility criteria is met, Patientory’s weight-loss program offers users a customized prescription plan. Under the guidance of qualified physicians, individuals receive a personalized plan, medication, and support. The first month’s package includes a medical telehealth consultation, prescription, one-month supply of Semaglutide medication, and shipping.
Semaglutide is part of a class of medications known as glucagon-like peptide-1 (GLP-1) receptor agonists. These drugs mimic the GLP-1 hormone, which is released in response to eating and stimulates insulin production to reduce blood glucose levels. Clinical trials have demonstrated that semaglutide can be effective in the promotion of weight loss.
Patientory was just named a “<a href="https://newsroom.bluecrossma.com/2024-01-24-BLUE-CROSS-BLUE-SHIELD-OF-MASSACHUSETTS-ANNOUNCES-2024-HEALTH-EQUITY-BUSINESS-ACCELERATOR-PARTICIPANTS?cid=2432&amp;utm_medium=&amp;utm_campaign=&amp;utm_source=organic+linkedin" rel="nofollow noopener" target="_blank">2024 Health Equity Business Accelerator Participant”</a> by Blue Cross Blue Shield of Massachusetts (BCBSMa) and received early-stage funding from VC firm Corridor Ventures, bringing their total in new seed investments to over $325K.
Kwamena Aidoo, Co-Founder and Managing Partner of Corridor Ventures said, “Connecting wearable device and electronic health records data has the potential to transform clinical research insights and evolve the way health and wellness care is administered across the globe.
Patientory sits at the forefront of this movement. When you think about this in the broader context of our rapidly changing technological landscape, it is hard not to get excited.”
 
About Patientory
Incorporated in 2015, Patientory Inc. offers a blockchain-based, HIPAA-compliant software platform. Patientory Inc. empowers patients, medical professionals, and healthcare organizations to securely access, store, and exchange health information in real-time with the highest levels of security. As the founding member of the Patientory Association, Patientory Inc. is powered by the PTOYMatrix blockchain network, which facilitates the secure and encrypted storage and exchange of health data.
 
<h5>Contact</h5>CEO Chrissa McFarlane Patientory, Inc. chrissa@patientory.com 
 
 
Disclaimer. This is a paid press release. CoinMarketCap does not recommend that any cryptocurrency (bitcoin, ethereum, custom asset) should be bought, sold or held. Do conduct your own due diligence and consult your financial advisor before making any investment decisions.

Healthcare Data Startup Patientory, Inc. Partners With WIVA For Capital (7 Feb)

Chainwire

Other articles published on Feb 7, 2024

Privacy Under Attack? Binance Delists Monero, Price Tanks

Bluesky, the Claimed Competitor of ‘X,’ is Now Available For All

John Deaton Challenges Security Status of Bitcoin, Ethereum, and XRP Amid New Crypto Regulations

Chainlink’s Bullish Retest Signals $21 Target Ahead!

NFT Polygon (MATIC) Turun 35 Persen, Ini Peluang Kripto Option2Trade (O2T)

This New Crypto Priced at $0.01 is Capturing Investors’ Attention, Poised for 50x Gains Surpassin...

Join our free newsletter for daily crypto updates!